Skip to main content
Premium Trial:

Request an Annual Quote

Decision Defense

The director of the US Centers for Disease Control and Prevention, Rochelle Walensky, has defended her decision to overrule an agency panel's decision on who should be eligible for COVID-19 vaccine boosters, saying that she made the decision on her own and based on her expertise, Stat News reports.

Last month, the Food and Drug Administration authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for individuals 65 years old or older as well as for some younger people at increased risk of contracting the virus. An outside expert panel to the CDC, which determines eligibility for the booster shot, then recommended limiting the third dose to older individuals and younger individuals with underlying medical conditions. Walensky, however, overrode the panel — the recommendations of which the CDC usually follows — to allow others at increased of contracting SARS-CoV-2 due to exposure at their jobs to also receive a booster.

The Times noted then that Walensky might not have had a choice, as the Biden Administration had been pushing for booster shots to be widely available to US adults.

But according to Stat News, Walensky says it was her own decision. "I know that if I had been in the room voting, I would have voted to offer boosters to that group, and that's ultimately where I laid," Walensky said to a group of reporters, according to Stat News.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.